User safety of topically administered products

Current version

PDF iconDraft guideline

Currently under revision - see below

Reference numberEMA/CVMP/SWP/721059/2014
Published27/06/2016
Keywordsantimicrobial, summary of product characteristics, SPC, veterinary medicinal products, responsible use, resistance, susceptibility testing, breakpoints
DescriptionThe guideline, which was developed to encourage optimal use and to minimise selection of antimicrobial resistance (AMR), was revised in order to improve consistency of the summary of product characteristics (SPCs) for antimicrobial products in the EU Member States.


Document history

First version
In progress

Adopted guideline

PDF iconOverview of comments


PDF iconDraft guideline


PDF iconConcept paper

Published: 07/05/2018
Effective from: 01/11/2018

Published: 07/05/2018

Published: 27/06/2016
Deadline for comments: 31/12/2016


Published: 14/04/2005


Related content


How useful was this page?

Add your rating
Average
3 ratings
2 ratings
1 rating